LNCARSR and neoplasm: Additionally the non-coding transcript lncARSR (activated in RCC with Sunitinib Resistance) that is transmitted via exosomes, showed increased levels in the serum of RCC patients, decreased after tumor resection and subsequently increased again during tumor relapse making it an interesting candidate for non-invasive disease monitoring (68).